4/9
08:09 am
cc
The Chemours Company (NYSE: CC) was upgraded by analysts at BMO Capital Markets from an "underperform" rating to an "outperform" rating. They now have a $34.00 price target on the stock, up previously from $19.00.
Low
Report
The Chemours Company (NYSE: CC) was upgraded by analysts at BMO Capital Markets from an "underperform" rating to an "outperform" rating. They now have a $34.00 price target on the stock, up previously from $19.00.
4/9
05:46 am
cc
Rating for CC
Low
Report
Rating for CC
4/9
05:46 am
cc
Rating for CC
Low
Report
Rating for CC
4/2
04:06 pm
cc
Rating for CC
Medium
Report
Rating for CC
4/2
02:12 pm
cc
Rating for CC
Low
Report
Rating for CC
4/2
02:12 pm
cc
Rating for CC
Low
Report
Rating for CC
3/5
07:43 am
cc
The Chemours Company (NYSE: CC) was downgraded by analysts at UBS Group AG from a "buy" rating to a "neutral" rating. They now have a $21.00 price target on the stock, down previously from $37.00.
Medium
Report
The Chemours Company (NYSE: CC) was downgraded by analysts at UBS Group AG from a "buy" rating to a "neutral" rating. They now have a $21.00 price target on the stock, down previously from $37.00.
3/5
05:57 am
cc
Rating for CC
Medium
Report
Rating for CC
3/1
09:07 am
cc
Rating for CC
Medium
Report
Rating for CC
3/1
09:07 am
cc
Rating for CC
Medium
Report
Rating for CC
2/29
12:36 pm
cc
Rating for CC
Low
Report
Rating for CC
2/29
12:36 pm
cc
Rating for CC
Low
Report
Rating for CC
2/29
08:47 am
cc
The Chemours Company (NYSE: CC) was downgraded by analysts at BMO Capital Markets from an "outperform" rating to an "underperform" rating. They now have a $19.00 price target on the stock, down previously from $45.00.
Medium
Report
The Chemours Company (NYSE: CC) was downgraded by analysts at BMO Capital Markets from an "outperform" rating to an "underperform" rating. They now have a $19.00 price target on the stock, down previously from $45.00.